Royal Bank Of Canada Abiomed Inc Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $1.7 Million - $2.11 Million	7,003 Added 9.94%	77,477 $19 Million
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $755,317 - $1.14 Million	-3,361 Reduced 4.55%	70,474 $17.4 Million
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $2.81 Million - $3.71 Million	10,119 Added 15.88%	73,835 $24.5 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $2.17 Million - $2.68 Million	-7,230 Reduced 10.19%	63,716 $22.9 Million
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $3.39 Million - $4.11 Million	-10,920 Reduced 13.34%	70,946 $23.1 Million
Q2 2021 Aug 16, 2021	BUY	$262.71 - $351.17 $21.5 Million - $28.7 Million	81,866 New	81,866 $25.6 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.